Traws Pharma Inc. Revenue 2011–2025
Traws Pharma Inc. annual/quarterly revenue history and growth rate from 2011 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Traws Pharma Inc. revenue for the quarter ending June 30, 2025 was 2.7 M, a 4694.74% increase year-over-year.
- Traws Pharma Inc. revenue for the twelve months ending June 30, 2025 was 2.9 M, a 1184.96% increase year-over-year.
- Traws Pharma Inc. annual revenue for 2025 was 2.8 M, a 1134.51% increase from 2024.
- Traws Pharma Inc. annual revenue for 2024 was 226000, a 0.00% increase from 2023.
- Traws Pharma Inc. annual revenue for 2023 was 226000, a 0.00% increase from 2022.
- Traws Pharma Inc. annual revenue for 2022 was 226000.
Traws Pharma Inc. (TRAW) — Frequently Asked Questions
Traws Pharma Inc. (TRAW) is a publicly traded US company. It has a market capitalization of $10M. In fiscal 2025 it reported revenue of $3M and net income of $9M. Explore TRAW's stock price, financial statements, earnings history, margins and key ratios below.
What is Traws Pharma Inc.'s market cap?
Traws Pharma Inc. (TRAW) has a market capitalization of $10M.
What is the TRAW stock price?
TRAW trades at $1.25 (-4.58% on the day).
How much revenue does Traws Pharma Inc. make?
Traws Pharma Inc. reported revenue of $3M in fiscal 2025.
Is TRAW profitable?
In fiscal 2025, Traws Pharma Inc. reported net income of $9M.
What is TRAW's P/E ratio?
Based on diluted EPS, TRAW has a price-to-earnings (P/E) ratio of about 1.5.